| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10762727 | Biochemical and Biophysical Research Communications | 2011 | 7 Pages |
Abstract
⺠We previously reported the novel targeted “hybrid peptide”. ⺠We generated a novel peptide, Sema3A-lytic hybrid peptide. ⺠This peptide had cytotoxic activity against NRP1-positive pancreatic cancer cells. ⺠In addition, this peptide did not affect the viability of normal cells in vitro. ⺠Hybrid peptide might provide a selective anticancer therapy to cancer patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Hanae Ueyama, Tomohisa Horibe, Oumi Nakajima, Koji Ohara, Masayuki Kohno, Koji Kawakami,